4598 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Delta-Fly Pharma, Inc. engages in the manufacturing, sale, research and development of pharmaceutical products for cancer treatment. It also provides module technology for motorcars, telepone, oncology drug discovery, treating metastatic ovarian cancer with DFP-10825, liposome-conjugated RNAi molecule and others. The company was founded by Kiyoshi Eshima on December 6, 2010 and is headquartered in Tokushima, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
4598 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company